These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 17947967)

  • 61. From the Centers for Disease Control and Prevention. Licensure of inactivated hepatitis A vaccine and recommendations for international travelers' use.
    JAMA; 1995 Aug 23-30; 274(8):603. PubMed ID: 7637131
    [No Abstract]   [Full Text] [Related]  

  • 62. Mucosal immunization against hepatitis A: antibody responses are enhanced by co-administration of synthetic oligodeoxynucleotides and a novel cationic lipid.
    Mitchell LA; Joseph A; Kedar E; Barenholz Y; Galun E
    Vaccine; 2006 Jun; 24(25):5300-10. PubMed ID: 16714070
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vaccination of newborns against hepatitis A in the presence of maternally derived antibodies.
    Vidor E
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S42-5. PubMed ID: 17555761
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immune serum globulin for protection against viral hepatitis. Recommendation of the Public Health Service Advisory Committee on Immunization Practices.
    Ann Intern Med; 1972 Sep; 77(3):427-30. PubMed ID: 4115456
    [No Abstract]   [Full Text] [Related]  

  • 65. Clinical inquiries: Who should get hepatitis A vaccination?
    Brown R; Cable K; Sams R
    J Fam Pract; 2005 Jul; 54(7):624-5; discussion 624. PubMed ID: 16009092
    [No Abstract]   [Full Text] [Related]  

  • 66. Are you up to date with new immunization recommendations?
    Campos-Outcalt D
    J Fam Pract; 2006 Mar; 55(3):232-4. PubMed ID: 16510057
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acute hepatitis A in a young returning traveler from Kenya despite immunization before departure.
    Senn N; Genton B
    J Travel Med; 2009; 16(1):72-3. PubMed ID: 19192136
    [TBL] [Abstract][Full Text] [Related]  

  • 68. FDA approval for a combined hepatitis A and B vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Sep; 50(37):806-7. PubMed ID: 11785573
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial.
    Jiang WP; Chen JT; Wang X; Wang YL; Liu Y; Chen WY; Xu WG; Qiu YZ; Yin WD
    Vaccine; 2008 Apr; 26(18):2297-301. PubMed ID: 18395305
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunizing children to protect against the increasing risk of hepatitis A in adolescents and young adults in South Korea.
    Sohn YM; Lee JS; Park JH; Poerschke G; Eves K; Gress J; Kuter B
    Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):954-8. PubMed ID: 15916097
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hepatitis A and B booster recommendations: implications for travelers.
    Zuckerman JN; Connor BA; von Sonnenburg F
    Clin Infect Dis; 2005 Oct; 41(7):1020-6. PubMed ID: 16142669
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Hepatitis-A vaccination in children].
    Gendrel D
    Med Trop (Mars); 2004; 64(4):394-400. PubMed ID: 15615396
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epaxal: a virosomal vaccine to prevent hepatitis A infection.
    Bovier PA
    Expert Rev Vaccines; 2008 Oct; 7(8):1141-50. PubMed ID: 18844588
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatitis A vaccine versus immunoglobulin for post-exposure prophylaxis.
    Srivastava A; Aggarwal R
    Natl Med J India; 2007; 20(6):302-3. PubMed ID: 18335798
    [No Abstract]   [Full Text] [Related]  

  • 75. Immune serum globulin for protection against viral hepatitis. Condensed recommendations of the Public Health Service Advisory Committee on Immunization Practices.
    Clin Pediatr (Phila); 1973 Jan; 12(1):5 passim. PubMed ID: 4739169
    [No Abstract]   [Full Text] [Related]  

  • 76. Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program.
    Chodick G; Heymann AD; Ashkenazi S; Kokia E; Shalev V
    J Viral Hepat; 2008 Oct; 15 Suppl 2():62-5. PubMed ID: 18837837
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunogenicity of hepatitis A-inactivated vaccine administered to seronegative infants, and serological follow-up 12 months after second dose.
    De Silvestri A; Zara F; Terulla V; Brerra R; Zucca S; Belloni C
    Acta Paediatr; 2006 Dec; 95(12):1582-5. PubMed ID: 17129966
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunization against Hepatitis A.
    Shouval D
    Cold Spring Harb Perspect Med; 2019 Feb; 9(2):. PubMed ID: 29661808
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Update on infectious disease prevention: human papillomavirus, hepatitis A.
    Longworth DL
    Cleve Clin J Med; 2008 Jun; 75(6):402-3, 409-10. PubMed ID: 18595548
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
    Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
    J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.